SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$672,000
+14.9%
274,473
+91.1%
0.01%
+9.1%
Q2 2021$585,000
+735.7%
143,639
+916.4%
0.01%
+1000.0%
Q4 2020$70,00014,1320.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders